Blog
RSS FeedPosted by Michael Wonder on 06 Apr 2021
'It's huge': life-changing cystic fibrosis drug a step closer to being funded by PHARMAC
5 April 2021 - Straight after waking up, Claire Scofield begins each day with a series of treatments – nebulizers, ...
Posted by Michael Wonder on 06 Apr 2021
Decision to widen access to secukinumab for psoriatic arthritis and ankylosing spondylitis
1 April 2021 - PHARMAC is pleased to announce a decision to widen funded access to secukinumab (Cosentyx) for the ...
Posted by Michael Wonder on 04 Apr 2021
Cystic fibrosis medicine applications to be considered by PHARMAC and Medsafe in parallel
1 April 2021 - PHARMAC met this week with Vertex, a supplier of cystic fibrosis medicines, and with Medsafe, the ...
Posted by Michael Wonder on 31 Mar 2021
New Zealand Pharmaceutical Schedule - 1 April 2021
1 April 2021 - The April 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 17 Mar 2021
Mythbusting PHARMAC
17 March 2021 - The agency is seeking to dispel some misunderstandings about what it does and how it does ...
Posted by Michael Wonder on 17 Mar 2021
PHARMAC’s drug switch
17 March 2021 - PHARMAC's generic drug swap for epilepsy treatment saved $30 million over five years. But for some ...
Posted by Michael Wonder on 16 Mar 2021
The PHARMAC compromise
17 March 2021 - One thing everybody involved with the inquest into the deaths of six epilepsy patients can agree on ...
Posted by Michael Wonder on 14 Mar 2021
PHARMAC review misses political elephant in the room
13 March 2021 - The governments of many developed nations fund medicines for their citizens after they have gone through independent ...
Posted by Michael Wonder on 10 Mar 2021
PHARMAC saving money at the expense of Kiwis' health
11 March 2021 - Peter Davis’ observations regarding PHARMAC funding new drugs every time there is a change of government ...
Posted by Michael Wonder on 09 Mar 2021
Request for proposals - supply of adalimumab
9 March 2021 - PHARMAC invites proposals for the supply of adalimumab in New Zealand. ...
Posted by Michael Wonder on 08 Mar 2021
Pacific pharmacists want inclusion on PHARMAC review
6 March 2021 - The President of the Pacific Pharmacists’Association, Kasey Brown, says a review of New Zealand’s drug buying ...
Posted by Michael Wonder on 08 Mar 2021
Jacinda Ardern responds to heartfelt plea from PHARMAC funding advocate Malcolm Mulholland
8 March 2021 - Prime Minister Jacinda Ardern has responded to a heartfelt plea by Malcolm Mulholland, a man advocating ...
Posted by Michael Wonder on 07 Mar 2021
Cancer Society says PHARMAC review doesn't go far enough
3 March 2021 - A review of drug buying agency PHARMAC is being described as long overdue. ...
Posted by Michael Wonder on 07 Mar 2021
PHARMAC does a great job, but it's losing the PR battle hands down
6 March 2021 - With each major change of government in recent years, PHARMAC has been required either to list ...
Posted by Michael Wonder on 04 Mar 2021
PHARMAC swapping epilepsy drugs 'cannot be discounted' as a cause of deaths — neurologist
4 March 2021 - An Auckland paediatric neurologist says PHARMAC's decision to switch to a generic version of an epilepsy drug ...